Tag: type 1 diabetes

McKee publishes article on automated insulin delivery 

On November 18, Alexis M. McKee, MD, CDCES had her article titled “What is Automated Insulin Delivery,” published on “EndocrineWeb.”  Automated insulin delivery (AID) delivers insulin through a pump that communicates with a continuous glucose monitor (CGM). Also known as a hybrid closed hoop system or an artificial pancreas device system.  In the article, McKee […]

McGill and sub-investigators’ trial for insulin-only bionic pancreas improves type 1 diabetes management 

On September 28, the National Institutes of Health released information on a pivotal trial for the insulin-only bionic pancreas study. The trial was led by principal investigator, Janet B. McGill, MD, and sub-investigators, Julie M. Silverstein, MD; Maamoun Salam, MD; Samantha Adamson, MD, PhD; and Andrea Cedeno, MD.   The bionic pancreas is unique, closed-loop insulin pump, […]

McGill, Salam and McKee get first patient for clinical trial testing Biosense device for those with Type 1 Diabetes 

Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug.  Biosense is a non-invasive option to capillary […]

McKee publishes article on Neutral Protamine Hagedorn insulin 

On September 12, Alexis McKee, MD published an article on “EndocrineWeb,” titled “What Is the Peak Time for NPH Insulin?”  “Insulin is a lifesaving hormone that is necessary for cells in your body to absorb sugar (glucose). Depending on the type of diabetes mellitus a person has, there can be a complete absence of insulin (type […]

McGill and Salam publish research on how continuous glucose monitoring reduces hypoglycemia 

On June 1, Janet B. McGill, MD, MA, FACP, Maamoun Salam, MD and colleagues has their work titled “Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use among Older Adults with Type 1 Diabetes,” published in “Diabetes Technology and Therapeutics.”  In the study, they evaluate the Wireless Innovation for […]

Williams receives LeJIT Teaching Award 

On July 18, Kelley Williams, MD was selected to receive the “LeJIT” Teaching Award for her excellence during the 2022 Block 3 Medicine Clerkship from May through June.   The award recognizes how Dr. Williams completed just-in-time (JIT) assessments and integrated them into her clinical and teaching workflows, providing meaningful and timely feedback to students. […]